Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
Meryem Grabski, Amy McAndrew, Will Lawn, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 152-162
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Ketamine treatment for depression: a review
Mani Yavi, Holim Lee, Ioline D. Henter, et al.
Discover Mental Health (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 85
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents
Christoph U. Correll, Marco Solmi, Samuele Cortese, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 48-74
Open Access | Times Cited: 82
Therapeutic effect of psilocybin in addiction: A systematic review
Pim B. van der Meer, Juan José Fuentes, Ad A. Kaptein, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 74
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
The abuse liability of ketamine: A scoping review of preclinical and clinical studies
Tuyen T. Le, Isabel Pazos Cordero, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research (2022) Vol. 151, pp. 476-496
Closed Access | Times Cited: 45
Psychedelic therapy in the treatment of addiction: the past, present and future
Rayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 38
Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression
August P. M. Lullau, E. Haga, Eivind Haga Ronold, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 38
Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review
Bess M. Kew, Richard Porter, Katie M. Douglas, et al.
BJPsych Open (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 35
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
João P. De Aquino, Matthew E. Sloan, Julio C. Nunes, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 391-402
Closed Access | Times Cited: 9
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
Cameron N. Calder, Angela T.H. Kwan, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 753-762
Closed Access | Times Cited: 8
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Jérémie Richard, Albert Garcia‐Romeu
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse
Marcus W. Meinhardt, Ivan Skorodumov, Jérôme Jeanblanc, et al.
Neuropsychopharmacology (2025)
Open Access | Times Cited: 1
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs
Marco Solmi, Chaomei Chen, Charles Daure, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 44-60
Open Access | Times Cited: 35
Toward Synergies of Ketamine and Psychotherapy
David S. Mathai, Victoria Mora, Albert Garcia‐Romeu
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 32
Active mechanisms of ketamine-assisted psychotherapy: A systematic review
Isak Joneborg, Yena Lee, Joshua D. Di Vincenzo, et al.
Journal of Affective Disorders (2022) Vol. 315, pp. 105-112
Closed Access | Times Cited: 30
Ketamine Treatment for Alcohol Use Disorder: A Systematic Review
Michael Kelson, Justin M Burnett, Amy Matthews, et al.
Cureus (2023)
Open Access | Times Cited: 19
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, et al.
Psychopharmacology (2023) Vol. 240, Iss. 7, pp. 1547-1560
Open Access | Times Cited: 18
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Muhammet Celik, Mark S. Gold, Brian Fuehrlein
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 294-294
Open Access | Times Cited: 7
Novel medications for problematic alcohol use
Markus Heilig, Katie Witkiewitz, Lara A. Ray, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 6
Short-chain fatty acid valerate reduces voluntary alcohol intake in male mice
Suresh Bokoliya, Jordan T. Russell, Yair Dorsett, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.
Nicolas Garel, Christina McAnulty, Kyle T. Greenway, et al.
Drug and Alcohol Dependence (2022) Vol. 239, pp. 109606-109606
Open Access | Times Cited: 25
The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review
Charlotte Goldfine, Jeremiah J. Tom, Dana D. Im, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 14
Effect of intraoperative and/or postoperative esketamine administration on preventing postpartum depression: A systematic review and meta-analysis
Jinping Wang, Hui Liu, Xinchuan Wei
Psychiatry Research (2024) Vol. 335, pp. 115890-115890
Closed Access | Times Cited: 5
Experiences of Awe Mediate Ketamine’s Antidepressant Effects: Findings From a Randomized Controlled Trial in Treatment-Resistant Depression
Julia Aepfelbacher, Benjamin Panny, Rebecca B. Price
Biological Psychiatry Global Open Science (2024) Vol. 4, Iss. 4, pp. 100316-100316
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top